These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 38670939)
1. Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxins. Aziz UBA; Saoud A; Bermudez M; Mieth M; Atef A; Rudolf T; Arkona C; Trenkner T; Böttcher C; Ludwig K; Hoelzemer A; Hocke AC; Wolber G; Rademann J Nat Commun; 2024 Apr; 15(1):3537. PubMed ID: 38670939 [TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate inhibits Streptococcus pneumoniae virulence by simultaneously targeting pneumolysin and sortase A. Song M; Teng Z; Li M; Niu X; Wang J; Deng X J Cell Mol Med; 2017 Oct; 21(10):2586-2598. PubMed ID: 28402019 [TBL] [Abstract][Full Text] [Related]
4. The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity. Shewell LK; Harvey RM; Higgins MA; Day CJ; Hartley-Tassell LE; Chen AY; Gillen CM; James DB; Alonzo F; Torres VJ; Walker MJ; Paton AW; Paton JC; Jennings MP Proc Natl Acad Sci U S A; 2014 Dec; 111(49):E5312-20. PubMed ID: 25422425 [TBL] [Abstract][Full Text] [Related]
5. Acacetin inhibits Streptococcus pneumoniae virulence by targeting pneumolysin. Li S; Lv Q; Sun X; Tang T; Deng X; Yin Y; Li L J Pharm Pharmacol; 2020 Aug; 72(8):1092-1100. PubMed ID: 32390150 [TBL] [Abstract][Full Text] [Related]
6. The cholesterol-dependent cytolysin pneumolysin from Streptococcus pneumoniae binds to lipid raft microdomains in human corneal epithelial cells. Taylor SD; Sanders ME; Tullos NA; Stray SJ; Norcross EW; McDaniel LS; Marquart ME PLoS One; 2013; 8(4):e61300. PubMed ID: 23577214 [TBL] [Abstract][Full Text] [Related]
7. Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms. Shak JR; Ludewick HP; Howery KE; Sakai F; Yi H; Harvey RM; Paton JC; Klugman KP; Vidal JE mBio; 2013 Sep; 4(5):e00655-13. PubMed ID: 24023386 [TBL] [Abstract][Full Text] [Related]
8. The solution structure and oligomerization behavior of two bacterial toxins: pneumolysin and perfringolysin O. Solovyova AS; Nöllmann M; Mitchell TJ; Byron O Biophys J; 2004 Jul; 87(1):540-52. PubMed ID: 15240487 [TBL] [Abstract][Full Text] [Related]
10. Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity. Kucinskaite-Kodze I; Simanavicius M; Dapkunas J; Pleckaityte M; Zvirbliene A Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32650398 [TBL] [Abstract][Full Text] [Related]
11. The TCM prescription Ma-xing-shi-gan-tang inhibits Streptococcus pneumoniae pathogenesis by targeting pneumolysin. Guo T; Guo Y; Liu Q; Xu Y; Wei L; Wang Z; Chen S; Wang C; Tian Y; Cui J; Wang Y; Wang Y; Sun L J Ethnopharmacol; 2021 Jul; 275():114133. PubMed ID: 33892068 [TBL] [Abstract][Full Text] [Related]
12. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Gilbert RJ; Jiménez JL; Chen S; Tickle IJ; Rossjohn J; Parker M; Andrew PW; Saibil HR Cell; 1999 May; 97(5):647-55. PubMed ID: 10367893 [TBL] [Abstract][Full Text] [Related]
13. The Yin and Yang of Pneumolysin During Pneumococcal Infection. Pereira JM; Xu S; Leong JM; Sousa S Front Immunol; 2022; 13():878244. PubMed ID: 35529870 [TBL] [Abstract][Full Text] [Related]
14. Apigenin protects mice from pneumococcal pneumonia by inhibiting the cytolytic activity of pneumolysin. Song M; Li L; Li M; Cha Y; Deng X; Wang J Fitoterapia; 2016 Dec; 115():31-36. PubMed ID: 27693741 [TBL] [Abstract][Full Text] [Related]
15. Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins. Baba H; Kawamura I; Kohda C; Nomura T; Ito Y; Kimoto T; Watanabe I; Ichiyama S; Mitsuyama M Biochem Biophys Res Commun; 2001 Feb; 281(1):37-44. PubMed ID: 11178957 [TBL] [Abstract][Full Text] [Related]
16. Quercetin, a pneumolysin inhibitor, protects mice against Streptococcus pneumoniae infection. Lv Q; Zhang P; Quan P; Cui M; Liu T; Yin Y; Chi G Microb Pathog; 2020 Mar; 140():103934. PubMed ID: 31862394 [TBL] [Abstract][Full Text] [Related]
17. Isorhamnetin as a novel inhibitor of pneumolysin against Streptococcus pneumoniae infection in vivo/in vitro. Zou Y; Wang H; Fang J; Sun H; Deng X; Wang J; Deng Y; Chi G Microb Pathog; 2023 Dec; 185():106382. PubMed ID: 37839759 [TBL] [Abstract][Full Text] [Related]
18. The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae. Rossjohn J; Gilbert RJ; Crane D; Morgan PJ; Mitchell TJ; Rowe AJ; Andrew PW; Paton JC; Tweten RK; Parker MW J Mol Biol; 1998 Nov; 284(2):449-61. PubMed ID: 9813129 [TBL] [Abstract][Full Text] [Related]
19. Structure-based functional studies for the cellular recognition and cytolytic mechanism of pneumolysin from Streptococcus pneumoniae. Park SA; Park YS; Bong SM; Lee KS J Struct Biol; 2016 Feb; 193(2):132-40. PubMed ID: 26688057 [TBL] [Abstract][Full Text] [Related]
20. Membrane perforation by the pore-forming toxin pneumolysin. Vögele M; Bhaskara RM; Mulvihill E; van Pee K; Yildiz Ö; Kühlbrandt W; Müller DJ; Hummer G Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13352-13357. PubMed ID: 31209022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]